锌对糖尿病大鼠血脂及脂质过氧化作用的影响

目的：观察锌对四氧嘧啶诱导的糖尿病大鼠脂质代谢及抗氧化系统的影响。方法：健康雄性Wistar大鼠32只,随机分成3组：正常对照组、糖尿病对照组、补锌组。补偿组每日以10mg/kgbw的Zn灌胃,60d以后,取血测血糖、胰岛素、血氧化指标等。结果：补锌组大鼠血糖较实验前明显降低;TC、TG水平明显低于阳性对照组;红细胞SOD、全血GSH－Px活力明显提高,MDA含量明显下降。结论：锌可以有效地缓解糖尿病大鼠的高血糖症状、纠正其血脂代谢紊乱、提高其抗氧化能力。     

血管紧张素转换酶和内皮素与糖尿病微血管病变的关系

目的 探讨血管紧张素转换酶（angiotensin converting enzyme,ACE)和血浆内皮素（endothelin,ET)水平与糖尿病微血管病变的关系。方法 用紫外分光光度法和直接放射免疫法测定55例糖尿病患者和30名正常人血清ACE和血浆ET水平。结果 糖尿病微血管病变患者血清ACE和血浆ET水平显著高于糖尿病无微血管病变患者,且随着糖尿病微血管病变的加重,血清ACE和血浆ET水平显著增高。糖尿病患者血清ACE和血浆ET水平呈显著正相关。结论 糖尿病微血管病变患者血清ACE和血清ET水平增高可能与糖尿病微血管病变的发生发展有关。     

玻璃体视网膜手术病因分析

目的：研究玻璃体视网膜手术的主要致病。方法：对449例玻璃体视网膜手术做回顾性分析,男243例,女206例,术前视力光感－0．2;平均病史11．6月,手术采用三切口闭合式玻璃体切割术,结果：449例诊断明确,与术前诊断符合率为80．6％,病因中视网膜血管性疾病114例,占25．39％,眼外伤85例,占18．93％,糖尿病视网膜病变82例,占18．26％,黄斑部病变41例,占9．13％,孔源性视网膜脱离39例,占8．69％,眼内炎25例,占5．57％,结论：玻璃体视网膜手术正走向成熟,其适应证逐渐扩展,已成为治疗眼后段疾病的重要手段。     

高血压性视网膜病变的视觉电生理改变探讨

目的：探讨高血压性视网膜病变的闪光视网膜电网（FERG）,振荡电位（OPs)改变,方法：比较正常对照组15例30只眼和不同眼底分毋组的原发性高血压病患者,共49例98只眼的FERG,OPs的变化。结果：1．FERG：a波潜伏期：对照组与I级组相比差异无显著性,与Ⅱ,Ⅲ级组相比差异均有显著性;I级组与Ⅱ级组间差异无显著性,但I级与Ⅲ级,Ⅱ级与Ⅲ级组间差异均有显著性;a波振幅：对照组与I级组间差异无显著性,与其他各组间差异均有显著性;各级患者组间差异均有显著性;b波潜伏期,除I级与II级组间差异无显著性外,其余各组间差异均显著;b波振幅;除对照组与I级组间差异无显著性外,其余各组间差异均有显著性,2．OPs潜伏期：对照组各子波与I级组以及OP1,OP4及Ⅱ级组间差异无显著性,与其他各组间差异均有显著性,I级各子波与II级组间差异无显著性,与Ⅲ级组间差异显著,Ⅱ级与Ⅲ级组间差异显著。OPs振幅：对照组OP3与I级组间差异无显著性,其余比较差异均有显著性,除I级与Ⅱ级组间的OP4振幅差异无显著性外,各级患者组间的各子波振幅以及总振幅差异均有显著性。结论：FERG,OPs可作为高血压性视网膜病变及其严重程度的客观定量指标。     

Bioactive glass,a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up

BackgroundThe bioactive glass (BAG) is a promising solution for the reconstruction of bone defects and the eradication of infection in patients with osteomyelitis, however references to the treatment of diabetic foot osteomyelitis are scarce in the literature.MethodsOur experience in patients with diabetic foot osteomyelitis, who required surgical debridement and void filling, in which we use bioactive glass (n = 6), was evaluated. During a minimum follow-up of 24 months, the presence of persistent infection and healing rate, post-surgical complications, surgical reinterventions, degree of osseointegration and BAG-related side effects was analyzed.ResultsAt the end of the follow-up, none of the patients showed signs of persistent infection and the healing rate was 66.6% (4/6).Postoperative complications were noted in 3 patients and two of the them required new surgical intervention, both due to skin coverage or vascular complications.A complete osseointegration in the 66.6% of the patients and no cases of local adverse effects were recorded.ConclusionsThe bioactive glass can be a useful tool in the treatment of certain cases of diabetic foot osteomyelitis, provided that a multidisciplinary approach and strict patient selection is in place.Level of evidenceIV.     

Conservative surgery for chronic diabetic foot osteomyelitis: Procedures and recommendations

Osteomyelitis (OM) is the most frequent infection associated with diabetic foot ulcers (DFU) that typically involve the forefoot, the most common location of DFU.Conservative surgical procedures could be attractive alternative that reduces minor and major amputations and avoid future recurrence thus preserving the functionally of the foot. This review aimed to analyze and describe the current evidence on conservative diabetic foot osteomyelitis (DFO) surgical procedures depending on DFU location and indications.A narrative revision of the evidence was carried out by searching Medline through PubMed databases from inception to late July 2020 to identify retrospective, prospective, and randomized controlled trials pertaining to conservative DFO procedures on the forefoot.Seven types of conservative surgical procedures for DFO treatment in the forefoot are described in this review: (1) partial or total distal phalangectomy, (2) arthroplasty of the proximal or distal interphalangeal joint, (3) distal Syme amputation, (4) percutaneous flexor tenotomy, (5) sesamoidectomy, (6) arthroplasty of the metatarsophalangeal joint, and (7) metatarsal head resection.When indicated, conservative surgery for DFUs in patients with chronic forefoot OM is a safe and effective option that increases the chances of healing and reduces the possibility of limb loss and death compared with radical amputation procedures.Since a lack of sufficient evidence supporting this procedure exists, future investigations should be focused on the random clinical trial (RCT) design. The results of prospective trials could help surgeons select the appropriate procedure in each case in order to minimize complications.     

Our experience of reinnervation of sole in diabetic sensorimotor polyneuropathy: A chance to change the natural history of disease

Diabetic sensorimotor polyneuropathy (DSPN) is the commonest form of neuropathy which leads to insensate sole, diabetic foot ulcers (DFU) and its complications. We share our experience in recovery of sensation in the sole after prophylactic surgery such as nerve decompression (ND) or sensory neurotization by nerve transfer (NT) in patients having Diabetic sensorimotor polyneuropathy DSPN. 32 patients (46 feet) were selected for either nerve decompression or sensory neurotization depending upon presence or absence of Tinel’s sign at tarsal tunnel. At 6 month post-operatively perception of touch and pain recovered in all feet; temperature and pressure perception recovered in ∼95% feet; average vibration perception threshold returned to normal range and 2-Point Discrimination came down significantly. There were no ulcers or amputation in operated limbs during follow up period of 6 months. Prophylactic surgery in the form of ND and NT can be offered with minimal complications which significantly improve sensations in the sole in selected cases of DSPN. These have the potential to improve the quality of life of patient and change the natural course of disease.     

中医药在糖尿病胃轻瘫治疗中的应用及思考

糖尿病胃轻瘫（DGP）发病率较高,药物治疗存在一定的局限性,部分患者可能出现一定的不良反应,这影响糖尿病的治疗。中药治疗DGP可以有效缓解患者症状,降低现有药物不良反应,辅助控制血糖。现代医家多利用辨证分型组方、经方验方及中成药进行辨病辨证治疗相结合,运用单味药、药对、中药提取物进行个体化治疗。现通过概述中药的多种组方思路,总结其优势,并对中药治疗DGP的现状进行思考与总结,以期中医药治疗DGP得到更好的发挥。     

中医药治疗糖尿病肾病实验研究进展

糖尿病肾病（DN）是糖尿病常见慢性并发症之一,白蛋白尿和肾小球滤过率下降是目前糖尿病肾病诊断的重要临床指征。DN严重影响着患者的生命质量,尽早地干预糖尿病肾病的危险因素,纠正胰岛素代谢障碍导致的长期高血糖因素影响下的肾脏损伤,是有效阻止其进展为终末期肾脏疾病的关键。中医药秉持其特色理论取得了独特的治疗优势,随着中医药对于DN的认识与研究的加深,实验研究方面也取得了一定的进展。本文总结了中医研究DN动物模型的常用构建方法,同时从中医药调节免疫炎症反应、降低氧化应激水平、改善肾脏血流动力学改变、纠正糖脂代谢紊乱等机制方面列举分析中医药辨治糖尿病实验研究进展,探讨中医药防治DN的机制,以期对临床有所裨益。     

基于TLR4/MyD88/NF-κB通路探究桃红四物汤对糖尿病周围神经病变大鼠炎症反应的影响

目的:探究桃红四物汤对糖尿病周围神经病变(DPN)大鼠炎症反应及对Toll样受体4(TLR4)/髓样分化因子88(MyD88)/核转录因子kappan B(NF-κB)通路的影响。方法:从45只SD大鼠中随机选取10只为对照组,其余35只大鼠建立DPN模型,3只大鼠建模失败,其余随机分为模型组,桃红四物汤低、高剂量组及α-硫辛酸组,每组各8只。桃红四物汤低、高剂量组分别给予4.5、18 g/(kg·d)的桃红四物汤,α-硫辛酸组给予α-硫辛酸20 mg/(kg·d),对照组及模型组给予等量的0.9%氯化钠溶液,均灌胃给药。连续给药8周后,检测大鼠血清炎症因子、血糖及血脂指标及神经传导情况,观察坐骨神经病理学变化,检测TLR4相关通路蛋白表达情况。结果:与对照组比较,模型组血清肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)及白细胞介素-6(IL-6)水平升高,血糖、糖化血红蛋白(HbA1c)、甘油三酯(TG)及血清总胆固醇(TC)水平升高,感觉神经传导速度(SNCV)及运动神经传导速度(MNCV)水平降低,TLR4、MyD88、NF-κB蛋白表达上调(P<0.05)...